<DOC>
	<DOCNO>NCT02276053</DOCNO>
	<brief_summary>This study conduct find whether lacosamide ( drug treat epilepsy ) effective routine clinical practice patient epilepsy cause brain tumor .</brief_summary>
	<brief_title>Study Lacosamide Adjunctive Drug Treatment Epilepsy Patients With Brain Tumors</brief_title>
	<detailed_description />
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Lacosamide</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<criteria>Patient never treat lacosamide ( LCM ) prior noninterventional study ( NIS ) treatment LCM first time start earlier 7 day prior enrollment NIS The decision treat physician prescribe LCM fall within current standard clinical practice , treatment decision clearly separate decision consider inclusion patient NIS A Patient Data Consent form sign dated patient and/or parent ( ) legal representative Patient male female ≥ 16 year age Patient must diagnosis brain tumorrelated epilepsy ( BTRE ) secondary lowgrade glioma ( World Health Organization Grade 1 2 time enrollment ) Patient retrospective Baseline seizure frequency least 1 partialonset seizure 8 week prior Visit 1 ( enrollment/ Baseline visit ) Patient previous diagnosis epilepsy tumor onset Patient brain metastasis Patient Karnofsky performance status scale index ≥ 60 % Patient currently take 12 Baseline antiepileptic drug ( AEDs ) epilepsy , LCM Patient receive maximum 4 different lifetime AEDs ever enter NIS</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>Brain tumor</keyword>
	<keyword>lacosamide ( LCM )</keyword>
	<keyword>Anti-Epileptic Drugs ( AEDs )</keyword>
</DOC>